PMC:7029759 / 9801-10064
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 237 | 28-37 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 242 | 189-205 | Chemical | denotes | oligonucleotides | MESH:D009841 |
| 249 | 71-81 | CellLine | denotes | MN908947.3 | CVCL:U508 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T179 | 9-15 | SO:0001026 | denotes | genome |
| T178 | 28-37 | SP_7 | denotes | 2019-nCoV |
| T177 | 146-167 | SO:0000646 | denotes | small interfering RNA |
| T176 | 169-174 | SO:0000646 | denotes | siRNA |
| T175 | 179-188 | SO:0000077 | denotes | antisense |
| T174 | 226-231 | NCBITaxon:10239 | denotes | virus |
| T173 | 253-259 | SO:0001026 | denotes | genome |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T44 | 5-8 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T45 | 9-15 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
| T46 | 164-167 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T47 | 249-252 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T48 | 253-259 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T86 | 226-231 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T25 | 189-205 | Chemical | denotes | oligonucleotides | http://purl.obolibrary.org/obo/CHEBI_7754 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T60 | 0-263 | Sentence | denotes | This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23. |